Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eunice Musvasva"'
Autor:
Doha Naga, Smaragda Dimitrakopoulou, Sonia Roberts, Elisabeth Husar, Susanne Mohr, Helen Booler, Eunice Musvasva
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Abstract In-vivo toxicity assessment is an important step prior to clinical development and is still the main source of data for overall risk assessment of a new molecular entity (NCE). All in-vivo studies are performed according to regulatory requir
Externí odkaz:
https://doaj.org/article/29caf756a49742ddb010ee163c88d7a3
Publikováno v:
Journal of Cheminformatics, Vol 14, Iss 1, Pp 1-19 (2022)
Abstract Unpredicted drug safety issues constitute the majority of failures in the pharmaceutical industry according to several studies. Some of these preclinical safety issues could be attributed to the non-selective binding of compounds to targets
Externí odkaz:
https://doaj.org/article/d4e4116dcb3e468a8a8dc68776a347cc
Autor:
Doha Naga, Smaragda Dimitrakopoulou, Sonia Roberts, Elisabeth Husar, Susanne Mohr, Helen Booler, Eunice Musvasva
In-vivo toxicity assessment is an important step prior to clinical development and is still the main source of data for overall risk assessment of a new molecular entity (NCE). All in-vivo studies are performed according to regulatory requirements an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aff8858ec323ce04a8a3997df28584a7
https://doi.org/10.1101/2022.08.06.503048
https://doi.org/10.1101/2022.08.06.503048
Publikováno v:
Journal of Cheminformatics
Unpredicted drug safety issues constitute the majority of failures in the pharmaceutical industry according to several studies. Some of these preclinical safety issues could be attributed to the non-selective binding of compounds to targets other tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c986e78ad16f5039a105caf11404f4c
https://phaidra.univie.ac.at/o:1673251
https://phaidra.univie.ac.at/o:1673251
Unpredicted drug safety issues constitute the majority of failures in the pharmaceutical industry according to several studies[1-3]. Some of these preclinical safety issues could be attributed to the non-selective binding of compounds to targets othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48fcc97e56b41ca40def6fce5901d5fc
https://doi.org/10.21203/rs.3.rs-957525/v1
https://doi.org/10.21203/rs.3.rs-957525/v1
Autor:
Lorrene A. Buckley, Eunice Musvasva, Karen Price, Ralston Sherry L, Joanne Birkebak, Aida Sacaan, Donna Dambach
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 102
Interest in developing combination products to overcome drug resistance and treat complex diseases is growing. However, ambiguity remains around the value of combination toxicity studies to support combination products. Therefore, the IQ* DruSafe Lea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::518a4163cec124c08b0d30b1d9a57ff6
https://pubmed.ncbi.nlm.nih.gov/30576687
https://pubmed.ncbi.nlm.nih.gov/30576687
Autor:
Lori Gallenberg, Lewis B Kinter, Eunice Musvasva, Enaksha R Wickremsinhe, Christopher Bruce, Qin C Ji, Gary Emmons, Christopher A. Evans
Publikováno v:
Bioanalysis. 2:1355-1359
Representing the first industry-led workshop on this topic, the Drug Information Association (DIA) and Pharmaceutical Research and Manufacturers of America (PhRMA) cosponsored a workshop on dried blood spots (DBS) sampling in the pharmaceutical indus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3562bfd9fb4b53f682fbee6cb3b51509
https://doi.org/10.4155/bio.10.101
https://doi.org/10.4155/bio.10.101